NCT05363150 is a clinical trial in Cancer, sponsored by Seoul National University Hospital.

Who is sponsoring NCT05363150?

NCT05363150 is sponsored by Seoul National University Hospital.

What condition does NCT05363150 study?

NCT05363150 studies Cancer, Prehabilitation.

Is NCT05363150 still recruiting?

NCT05363150 is currently status unknown. Last updated 11 May 2022.

Last reviewed 2022-05-11 · How we verify

NCT05363150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of a Smart Device Application for Home-based Prehabilitation

Status unknown Last updated 11 May 2022

What this trial tests

trial in Cancer in 20 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
1 September 2022

1 December 2022

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 June 2022
Primary completion	1 September 2022
Estimated completion	1 December 2022

Conditions studied

Cancer — all drugs for Cancer →
Prehabilitation — all drugs for Prehabilitation →

Sponsor

Seoul National University Hospital

Who can join

Adults 19 to 70, any sex, with Cancer or Prehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the feasibility of a home-based exercise training program using a smartphone application in patients planning for cancer surgery, and to determine the effectiveness of this application on functional capacity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05363150 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 11 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05363150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing